A pilot study of epidoxorubicin (NSC 256942) in combination treatment of acute leukaemia and non-Hodgkin's lymphoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/D07E2AC6.svg?ark=w1%2F20260515%2FD07E2AC6)](https://nobleid.org/work/w1/20260515/D07E2AC6)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors